Reimbursed with a limitationOriginator productATC A10BD16

Vokanamet

Vokanamet is an originator product from Janssen-Cilag AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 56.40 to CHF 192.30 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Janssen-Cilag AG
ATC code
A10BD16
IT group
07.06.20 Orale blutzuckersenkende Mittel
Active substances
Canagliflozinum, Metformini hydrochloridum
Preparation type
Originator product
On the SL since
01/12/2014
Last price change
01/12/2023
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Vokanamet Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 50/850 mgFl 60 StkCHF 36.76CHF 56.4001/12/2014B7680632390026
Filmtabl 50/850 mg3 Fl 60 StkCHF 106.91CHF 132.7001/12/2014B7680632390033
Filmtabl 50/1000 mgFl 60 StkCHF 36.76CHF 56.4001/12/2014B7680632390057
Filmtabl 50/1000 mg3 Fl 60 StkCHF 106.91CHF 132.7001/12/2014B7680632390064
Filmtabl 150/850 mgFl 60 StkCHF 53.91CHF 75.0501/12/2014B7680632390088
Filmtabl 150/850 mg3 Fl 60 StkCHF 161.71CHF 192.3001/12/2014B7680632390095
Filmtabl 150/1000 mgFl 60 StkCHF 53.91CHF 75.0501/12/2014B7680632390118
Filmtabl 150/1000 mg3 Fl 60 StkCHF 161.71CHF 192.3001/12/2014B7680632390125

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/07/2019

Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, wenn durch Diät und gesteigerte körperliche Aktivität keine ausreichende Kontrolle der Glykämie erreicht wird:
• Anstelle von Metformin, wenn mit der maximal tolerierten Dosis Metformin allein oder in Kombination mit einem Sulfonylharnstoff, einem DPP4-Inhibitor oder Insulin keine ausreichende Kontrolle der Glykämie erreicht wird.
• Als Ersatz für die bereits separat verabreichten Wirkstoffe Canagliflozin und Metformin.

FAQ

Is Vokanamet covered by Swiss health insurance?

Yes, but only under conditions. Vokanamet is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Vokanamet cost in Switzerland?

The public price is the maximum price set by the FOPH and for Vokanamet ranges from CHF 56.40 to CHF 192.30 per pack. The ex-factory price ranges from CHF 36.76 to CHF 161.71. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com